| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Andrew D Lipman last filed a Form 4 in May 2024, as Director at NUS. From May 2015 to May 2024, the filings on record show 0 open-market purchases and 31 sales. Andrew D Lipman's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Historically, Andrew D Lipman's trades have earned a strong insider score of 85/100 across 30 rated trades. Over a 12-month horizon, all 30 of those trades were profitable, with an average 12-month return of +48.1%.
At the last filing, the largest reported position was 23,225 shares of NUS. The NUS filings lean toward selling, a net 89,400 shares.
Shares as reported in the last Form 4 for each company; the most recent is from May 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2016 | NUS Nu Skin Enterprises, Inc. | Director | Sell | 30,000 | $64.13 | $1,923,900.00 | -45.4% |